Suppliers / ShanghaiCdymaxPharmaceuticalsCo.,Ltd

ShanghaiCdymaxPharmaceuticalsCo.,Ltd

China Updated 9 July 2026

ShanghaiCdymaxPharmaceuticalsCo.,Ltd is an API manufacturer based in China.

0
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Carboplatin PMDA (Japan) 1

Also appears on these molecule pages

Carboplatin API

Questions about ShanghaiCdymaxPharmaceuticalsCo.,Ltd

What does ShanghaiCdymaxPharmaceuticalsCo.,Ltd make?
1 molecule is on record against ShanghaiCdymaxPharmaceuticalsCo.,Ltd, including Carboplatin. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. ShanghaiCdymaxPharmaceuticalsCo.,Ltd comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Hetero shares 1 molecule Cipla shares 1 molecule Laurus Labs shares 1 molecule Veranova Lp shares 1 molecule Qilu Pharmaceutical shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability